SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LFMD

LifeMD, Inc. (NASDAQ:LFMD)

US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
$1.45-$0.15 (-9.40%)
 
Market cap
$69.8M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 29, 2008
Website
Market Cap$69.84M-63.6%
Revenue (ttm)$188.94M-25.1%
Net Income-$21.92M-376.3%
EPS-$0.52-204.7%
Shares Out48.33M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,581,307
Open$1.54
Previous Close$1.59
Day's Range$1.39 - $1.54
52-Week Range$1.38 - $5.38
Beta2.16
AnalystsBuy
Price Target$7.00(+384.43%)
Earnings DateMar 8, 2027

About LFMD

LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.

Address
236 Fifth Avenue, New York City, NY, 10001, US
Market Cap
70 million
Employees
350
Industrial Classification
Medical - Healthcare Information Services

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$54.15K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $8.00 (+453.6%)

1 firm rating LFMD in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From LFMD’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-9.40%
5 Days
-30.53%
1 Month
-33.41%
6 Months
-65.51%
1 Year
-63.60%

$LFMD stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in LFMD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by LFMD's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

LFMD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

LFMD Revenue by Segment

$54.73MTotal
Telehealth revenue, net$44.63M81.54%
Cost of telehealth revenue$8.25M15.07%
Merchant processing fees$1.86M3.39%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New LFMD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to LFMD from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in LFMD

VTIVanguard Morningstar Total Stock Market ETF$2.21M
IWMiShares Russell 2000 ETF$1.55M
VXFVanguard Extended Market ETF$1.09M
KOMPState Street SPDR S&P Kensho New Economies Composite ETF$864.15K
VTWOVanguard Russell 2000 ETF$544.50K
IWOiShares Russell 2000 Growth ETF$459.98K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from LFMD’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
32

News check: LifeMD faced Q3 earnings miss with widening losses and revenue shortfall; analyst downgraded price target, citing execution risks.

Recent Insider Activity

Buys
0
Sells
1
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

FDHTFIDELITY DIGITAL HEALTH ETF0.63%
EDOCGlobal X Telemedicine & Digital Health ETF0.39%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.11%
SQLVRoyce Quant Small-Cap Quality Value ETF0.09%
BUYOKraneShares Man Buyout Beta Index ETF0.05%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF0.04%
QSMLWisdomTree U.S. SmallCap Quality Growth Fund0.01%
JPSEJPMorgan Diversified Return U.S. Small Cap Equity ETF0.00%

Weight is the stock’s share of each fund’s holdings.